article

1. Agreement of Administrative Pharmacy Dispensing With Self-Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis..  Arthritis care & research.  77:1350-1358. 2025
2. Development and External Validation of a Genetic Risk Score for Pain in Rheumatoid Arthritis..  Arthritis care & research.  2025
3. Genetically-determined variation in CRP impacts disease activity assessment in rheumatoid arthritis..  Rheumatology (Oxford, England).  64:3921-3928. 2025
4. Prevalence of Frailty and Associated Factors in a US-Wide Cohort of Rheumatic Diseases..  ACR open rheumatology.  7:-. 2025
5. Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease..  Arthritis & rheumatology (Hoboken, N.J.).  77:971-980. 2025
6. Advancing Rheumatologic Care in Older Adults: Highlights From the 2024 American Geriatrics Society Annual Scientific Meeting..  Arthritis care & research.  77:557-563. 2025
7. Improving High-Risk Osteoporosis Medication Adherence and Safety With an Automated Dashboard..  Federal practitioner : for the health care professionals of the VA, DoD, and PHS.  42:96-99. 2025
8. Development and internal validation of a clinical and genetic risk score for rheumatoid arthritis-associated interstitial lung disease..  Rheumatology (Oxford, England).  64:268-275. 2025
9. Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas..  Arthritis care & research.  77:23-29. 2024
10. Frailty integration in medical specialties: Current evidence and suggested strategies from the Clin-STAR frailty interest group..  Journal of the American Geriatrics Society.  73:1029-1040. 2024
11. Frailty and rheumatic diseases: evidence to date and lessons learned..  The Lancet. Rheumatology.  6:e881-e891. 2024
12. Change in frailty among older COVID-19 survivors..  Journal of the American Geriatrics Society.  72:3800-3809. 2024
13. MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung Disease..  Rheumatology (Oxford, England).  2024
14. Frailty and its association with readmissions in patients with rheumatoid arthritis: A national readmissions database study..  Clinical rheumatology.  43:3639-3646. 2024
15. A Remote Behaviorally Designed Intervention to Promote Physical Activity in Patients With Knee Osteoarthritis: Results of a Pilot Randomized Clinical Trial..  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.  30:336-339. 2024
16. Associations Between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis..  The Journal of clinical endocrinology and metabolism.  109:e1839-e1846. 2024
17. Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritis..  Rheumatology (Oxford, England).  63:1998-2005. 2024
18. Antibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US Veterans..  Arthritis & rheumatology (Hoboken, N.J.).  76:1353-1363. 2024
19. Mortality with concurrent treatment with gabapentin and opioids among people with spine diagnoses in the U.S. Medicare population: a propensity-matched cohort study..  medRxiv : the preprint server for health sciences.  2024
20. Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort..  Arthritis & rheumatology (Hoboken, N.J.).  76:1013-1022. 2024
21. Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs..  Arthritis care & research.  76:627-635. 2024
22. Psychometric Properties of Frailty Instruments in Adults With Rheumatoid Arthritis: A Systematic Review..  ACR open rheumatology.  6:91-102. 2023
23. Erratum to "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective" [The Journal of Arthroplasty 38 (2023) 2193-2201]..  The Journal of arthroplasty.  39:851-852. 2023
24. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis..  Arthritis care & research.  75:2405-2419. 2023
25. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis..  Arthritis & rheumatology (Hoboken, N.J.).  75:2088-2102. 2023
26. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective..  The Journal of arthroplasty.  38:2193-2201. 2023
27. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective..  Arthritis care & research.  75:2227-2238. 2023
28. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective..  Arthritis & rheumatology (Hoboken, N.J.).  75:1877-1888. 2023
29. Corticosteroid Injections for Symptomatic Treatment of Osteoarthritis of the Knee: A Pilot Blinded Randomized Trial..  ACR open rheumatology.  5:529-535. 2023
30. Racial and Ethnic Differences in a Biochemical Marker of Rheumatoid Arthritis Disease Activity..  ACR open rheumatology.  5:142-148. 2023
31. Elevations in adipocytokines and mortality in rheumatoid arthritis..  Rheumatology (Oxford, England).  61:4924-4934. 2022
32. The Impact of Disease Severity Measures on Survival in U.S. Veterans with Rheumatoid Arthritis-Associated Interstitial Lung Disease..  Rheumatology (Oxford, England).  61:4667-4677. 2022
33. Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis..  Arthritis care & research.  75:768-777. 2022
34. Risk factors for osteoporosis and fractures in rheumatoid arthritis..  Best practice & research. Clinical rheumatology.  36:-. 2022
35. Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease..  Seminars in arthritis and rheumatism.  -. 2022
36. Physical Function and Fatigue Recovery at 6-Months after Hospitalization for COVID-19..  PM & R : the journal of injury, function, and rehabilitation.  15:314-324. 2022
37. Protocol for a multi-center randomized controlled trial to evaluate the benefits of exercise incentives and corticosteroid injections in osteoarthritis of the knee (MOVE-OK)..  Trials.  23:-. 2022
38. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study..  The Lancet. Rheumatology.  4:e603-e613. 2022
39. Osteoporosis and fractures in rheumatoid arthritis - risk factors..  Best practice & research. Clinical rheumatology.  36:-. 2022
40. Adipocytokines and achievement of low disease activity in rheumatoid arthritis..  Seminars in arthritis and rheumatism.  -. 2022
41. Reply to letters to the Editor re: Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort..  Seminars in arthritis and rheumatism.  -. 2022
42. Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort..  Seminars in arthritis and rheumatism.  -. 2022
43. Non-English Language Preference Associated With Decreased Rheumatology Telehealth Use During the COVID-19 Pandemic..  ACR open rheumatology.  4:385-394. 2022
44. Patient-reported functional outcomes 30 days after hospitalization for COVID-19..  PM & R : the journal of injury, function, and rehabilitation.  14:173-182. 2021
45. Comment on: Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events..  Rheumatology (Oxford, England).  60:e184-e185. 2021
46. Osteoporosis and fractures in rheumatoid arthritis..  Current opinion in rheumatology.  33:270-276. 2021
47. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry..  Annals of the rheumatic diseases.  79:859-866. 2020
48. Sex differences in frailty and its association with low bone mineral density in rheumatoid arthritis..  Bone reports.  -. 2020
49. Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus..  Lupus science & medicine.  7. 2020
50. The Impact of Frailty on Changes in Physical Function and Disease Activity Among Adults With Rheumatoid Arthritis..  ACR open rheumatology.  1:366-372. 2019
51. Association of High Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index With Low Bone Mineral Density in Rheumatoid Arthritis..  Arthritis care & research.  70:961-969. 2018
52. Antimalarial myopathy in a systemic lupus erythematosus patient with quadriparesis and seizures: a case-based review..  Clinical rheumatology.  36:1437-1444. 2017
53. Cervical Spinal Fracture and Other Diagnoses Associated With Mortality in Hospitalized Ankylosing Spondylitis Patients..  Arthritis care & research.  69:271-277. 2017